Brief: Revelation Biosciences Says Safety Monitoring Committee Recommends Continuing Evaluation Of Allergic Rhinitis Treatment
23/05/2022 14:07
May 23 (Reuters) - Revelation Biosciences Inc REVB.O :
* REVELATION BIOSCIENCES INC. ANNOUNCES SAFETY MONITORING
COMMITTEE RECOMMENDATION FOR CONTINUING EVALUATION OF REVTX-99B
FOR THE TREATMENT OF ALLERGIC RHINITIS
* REVELATION BIOSCIENCES INC - SMC RECOMMENDED CONTINUATION
OF
STUDY WITHOUT MODIFICATION
* REVELATION BIOSCIENCES INC - EXPECTS TOPLINE DATA IN Q3 OF
2022
Source text for Eikon: ID:nGNXc2Gl6m
Further company coverage: REVB.O
((Reuters.Briefs@thomsonreuters.com;))